Unichem Labs is one bright stock today morning. It rose almost 5% to hit an intraday high at Rs.267.65, on the back of robust volumes. Its 52-week high stands at Rs.304.20.
The market is happy with its new approvals. On Saturday, it received ANDA approval for its Atenolol and Chlorthalidone Tablets, from the United States Food and Drug Administration (USFDA).
This approval will now mean that it can market a generic version of Tenoretic (atenolol and chlorthalidone) Tablets of Alvogen Malta Operations.
Atenolol and Chlorthalidone tablets are used for for the treatment of hypertension, to lower blood pressure.
The product will be commercialized from Unichem’s Ghaziabad Plant.